[272 Pages Report] The global Contract Research Organization (CRO) services market is projected to reach USD 73.77 billion by 2025 from USD 47.77 billion in 2020, at a CAGR of 9.1% during the forecast period. Market growth can be attributed to the growing R&D expenditure, increased outsourcing of R&D activities, and an increasing number of clinical trials.
Based on type, clinical research accounted for the largest share, which can be attributed to rapid growth in the geriatric population and the subsequent increase in the prevalence of chronic diseases, increasing the development of new drugs, and growing acceptance of evidence-based medicine for various therapeutic areas.
The global CRO services market, by therapeutic area, is segmented into oncology, CNS disorders, infectious diseases, CVS disorders, metabolic disorders, respiratory disorders, immunological disorders, ophthalmology, and other therapeutic areas. The large share of the oncology segment can be attributed to the increasing number of clinical trials and the rising prevalence of cancer worldwide.
The large share of this segment can be attributed to the increased outsourcing of early phase development services and clinical and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate the process and product.
North America will continue to dominate the CRO services market during the forecast period Geographically, the global CRO services market has been segmented into five major regional segments—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the CRO services market in 2019, followed by Europe and Asia Pacific. North America’s leading position in this market is primarily attributed to the high-quality standards in the pharmaceutical industry, rapid growth in its biosimilar and biologics market, and an increase in clinical trial activity.
The prominent players in the global CRO services market are IQVIA (US), LabCorp (US), PAREXEL (US), PRA Health Sciences (US), PPD (US), ICON plc (Ireland), Syneos Health (US), Charles River (US), WuXi AppTech (China), SGS (Switzerland) and Medpace (US).
IQVIA dominates the CRO services market, led by its strong performance in the biopharmaceutical services industry with extensive geographical coverage. The company’s foothold in the market is primarily attributed to various factors such as strong technical and service capabilities, good client relationships, diversified service offerings, and its ability to expand the penetration of its offerings to a broad range. The company has registered significant growth in the biopharmaceutical services industry, and has a presence in all major markets, including the US, Japan, Germany, France, Spain, and Italy, in addition to Brazil, Russia, India, and China (BRIC countries). To increase its geographic presence and customer base, the company focused on expansion as a key growth strategy. Over the past three years, the company has made three major expansions. Moreover, IQVIA also focused on mergers and acquisitions to enhance and strengthen its position in the global market.
In this report, the CRO services market has been segmented into the following segments and subsegments:
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table Of Content
1 Introduction
1.1 Objectives of study
1.2 Market definition
1.3 Market scope
1.3.1 Markets covered
1.3.2 Years considered for the study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research approach
2.2 Market size estimation
2.3 Market breakdown and data triangulation
2.4 Market share estimation
2.4.1 Key data from secondary sources
2.5 Key data from primary sources
2.5.1 Key Industry Insights
2.6 Assumptions for the study
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Growing R&D expenditures
5.3.1.2 Increased outsourcing of R&D activities
5.3.1.3 Increasing demand of outsourcing analytical testing and clinical trial services
5.3.1.4 Increase in clinical trials
5.3.2 Restraints
5.3.2.1 Regulatory pressure on CROs
5.3.3 Opportunities
5.3.3.1 Growing biosimilars and biologics market
5.3.3.2 Rising demand for specialized testing services
5.3.4 Challenges
5.3.4.1 Growing competition in the CRO industry
5.3.4.2 Regulatory pressure on pharma and medical device manufacturers to drive more detailed chemical analysis of drugs, and devices
5.3.4.3 Shortage of skilled professionals
6 Industry Insight
6.1 Industry Trends
6.1.1 Growing consolidation in the CROs industry
6.1.2 Globalization of clinical trials
6.1.3 Increasing demnad of outsourcing various services and preferred vendor partnerships
6.1.4 Technological Advancement
7 Contract Research Organization Market, By Services
7.1 Introduction
7.2 Early Phase Development Services
7.2.1 Discovery Studies
7.2.2 Chemistry, Manufacturing & Control
7.2.3 Preclinical
7.2.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)
7.2.3.2 Toxicology Testing
7.2.3.3 Other Preclinical Services
7.3 Clinical Research Services
7.3.1 Phase I
7.3.2 Phase II
7.3.3 Phase III
7.3.4 Phase IV
7.4 Laboratory Services
7.4.1 Bioanalytical Testing
7.4.2 Analytical Testing
7.4.2.1 Physical Characterization
7.4.2.2 Stability Testing
7.4.2.3 Batch Release Testing
7.4.2.4 Raw Material Testing
7.4.2.5 Other Analytical Testing
7.5 Consulting Services
7.6 Data Management Services
8 Contract Research Organization Market, By Therapeutic Areas
8.1 Oncology
8.2 Central Nervous System
8.3 Cardiovascular
8.4 Respiratory
8.5 Infectious Diseases
8.6 Autoimmune Disorders
8.7 Diabetes
8.8 Others
9 Contract Research Organization Market, By End User
9.1 Pharmaceutical and Biopharmaceutical Companies
9.2 Medical Device Companies
9.3 Academic Institutes
10 Geographic Analysis
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 APAC
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 RoAPAC
10.4.5 Latin America
10.4.6 Middle East & Africa
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation & Trends
11.3.1 Agreements, collaborations, joint ventures, and partnerships
11.3.2 Expansions
11.3.3 Mergers and acquisitions
11.3.4 New Service launches
12 Company Profiles
12.1 IQVIA
12.2 LabCorp
12.3 Charles river Laboratories
12.4 WuXi Apptec
12.5 Syneos Health Inc.
12.6 Paraxel International
12.7 PRA Health Sciences
12.8 PPD
12.9 ICON Plc
12.10 Medpace Holdings
12.11 SGS
12.12 PSI CRO AG
12.13 Axcent Advanced Analytics (A3)
12.14 BIO Agile Therapeutics
12.15 Firma Clinical Research
12.16 Acculab Lifesciences
12.17 Azelix
12.18 CTSERV
12.19 PEPGRA
12.20 Dove Quality Solutions
13 Appendix
13.1 Insights of industry experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: MarketsandMarkets' Subscription Portal
13.5 Available customizations
13.6 Introducing RT: Real Time Market Intelligence
The study involved four major activities for estimating the size of the CRO services market. Exhaustive secondary research was done to collect information on the market, including its peer markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Various secondary sources such as the Association of Clinical Research Organizations (ACRO), Clinical Research Society (CRS), Clinical Research Association of Canada (CRAC), Association of International Contract Research Organizations (AICROS), Clinical and Contract Research Association (CCRA), American Association of Pharmaceutical Scientists (AAPS), annual reports/SEC filings as well as investor presentations, and press releases of key players have been used to identify and collect information useful for the study of the medical device cleaning market.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include CEOs, consultants, subject-matter experts, directors, general managers, developers, and other key opinion leaders of the various companies that offer CRO services.
Primary research was conducted to identify segmentation types, industry trends; technology trends; key players; and key market dynamics such as drivers, opportunities, challenges, and key player strategies.
Top-down and bottom-up approaches were used to validate the size of the global CRO services market and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases (such as Hoover’s, Bloomberg Business, Factiva, and Avention), and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The breakdown of profiles of primary research participants is shown in the figure below:
To know about the assumptions considered for the study, download the pdf brochure
IQVIA (US), LabCorp (US), Syneos Health (US), PAREXEL (US), PPD (US), ICON plc (Ireland), PRA Health Sciences (US), and Charles River (US) are some of the key players in the global CRO services market.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Benchmarking the rapid strategy shifts of the Top 100 companies in the Contract Research Organization Services (CROs) Market
Request For Special Pricing
Growth opportunities and latent adjacency in Contract Research Organization Services (CROs) Market